Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo.
van Eck van der Sluijs J, van Ens D, Brummelman J, Heister D, Sareen A, Truijen L, van Ingen Schenau DS, Heemskerk MHM, Griffioen M, Kester MGD, Schaap NPM, Jansen JH, van der Waart AB, Dolstra H, Hobo W. van Eck van der Sluijs J, et al. Among authors: van der waart ab. Cell Mol Life Sci. 2023 Sep 20;80(10):298. doi: 10.1007/s00018-023-04923-4. Cell Mol Life Sci. 2023. PMID: 37728691 Free PMC article.
siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.
van der Waart AB, Fredrix H, van der Voort R, Schaap N, Hobo W, Dolstra H. van der Waart AB, et al. Among authors: van der voort r. Cancer Immunol Immunother. 2015 May;64(5):645-54. doi: 10.1007/s00262-015-1668-6. Epub 2015 Feb 28. Cancer Immunol Immunother. 2015. PMID: 25724840 Free PMC article.
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.
van Eck van der Sluijs J, van Ens D, Thordardottir S, Vodegel D, Hermens I, van der Waart AB, Falkenburg JHF, Kester MGD, de Rink I, Heemskerk MHM, Borst J, Schaap NPM, Jansen JH, Xiao Y, Dolstra H, Hobo W. van Eck van der Sluijs J, et al. Among authors: van der waart ab. Cancer Immunol Immunother. 2021 Nov;70(11):3167-3181. doi: 10.1007/s00262-021-02899-3. Epub 2021 Apr 1. Cancer Immunol Immunother. 2021. PMID: 33796917 Free PMC article.
Targeting the IL17 pathway for the prevention of graft-versus-host disease.
van der Waart AB, van der Velden WJ, Blijlevens NM, Dolstra H. van der Waart AB, et al. Among authors: van der velden wj. Biol Blood Marrow Transplant. 2014 Jun;20(6):752-9. doi: 10.1016/j.bbmt.2014.02.007. Epub 2014 Feb 22. Biol Blood Marrow Transplant. 2014. PMID: 24565991 Free article. Review.
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.
van der Waart AB, van de Weem NM, Maas F, Kramer CS, Kester MG, Falkenburg JH, Schaap N, Jansen JH, van der Voort R, Gattinoni L, Hobo W, Dolstra H. van der Waart AB, et al. Among authors: van de weem nm, van der voort r. Blood. 2014 Nov 27;124(23):3490-500. doi: 10.1182/blood-2014-05-578583. Epub 2014 Oct 21. Blood. 2014. PMID: 25336630 Free PMC article.
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy.
Mousset CM, Hobo W, Ji Y, Fredrix H, De Giorgi V, Allison RD, Kester MGD, Falkenburg JHF, Schaap NPM, Jansen JH, Gattinoni L, Dolstra H, van der Waart AB. Mousset CM, et al. Among authors: van der waart ab. Oncoimmunology. 2018 Aug 6;7(10):e1488565. doi: 10.1080/2162402X.2018.1488565. eCollection 2018. Oncoimmunology. 2018. PMID: 30288356 Free PMC article.
Comprehensive Phenotyping of T Cells Using Flow Cytometry.
Mousset CM, Hobo W, Woestenenk R, Preijers F, Dolstra H, van der Waart AB. Mousset CM, et al. Among authors: van der waart ab. Cytometry A. 2019 Jun;95(6):647-654. doi: 10.1002/cyto.a.23724. Epub 2019 Feb 4. Cytometry A. 2019. PMID: 30714682 Free article. Review.
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity.
van Ens D, Mousset CM, Hutten TJA, van der Waart AB, Campillo-Davo D, van der Heijden S, Vodegel D, Fredrix H, Woestenenk R, Parga-Vidal L, Jansen JH, Schaap NPM, Lion E, Dolstra H, Hobo W. van Ens D, et al. Among authors: van der waart ab. Bone Marrow Transplant. 2020 Dec;55(12):2308-2318. doi: 10.1038/s41409-020-0966-6. Epub 2020 Jun 11. Bone Marrow Transplant. 2020. PMID: 32528120
21 results